Citations (69)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Tania Jain, Heidi E. Kosiorek, Thomas E. Grys, Shu Ting Kung, Vishal S. Shah, Jeffrey A. Betcher, James L. Slack, Jose F. Leis, Nandita Khera, Pierre Noel, Jeanne M. Palmer & Lisa Z. Sproat. (2019) Single dose versus multiple doses of rituximab for preemptive therapy of Epstein–Barr virus reactivation after hematopoietic cell transplantation. Leukemia & Lymphoma 60:1, pages 110-117.
Read now
Read now
Muir Morton, Beatrice Coupes, James Ritchie, Stephen A. Roberts, Paul E. Klapper, Richard J. Byers, Pamela J. Vallely, Kate Ryan & Michael L. Picton. (2016) Post-transplant lymphoproliferative disorder in adult renal transplant recipients: survival and prognosis. Leukemia & Lymphoma 57:2, pages 299-305.
Read now
Read now
Amit Sharma, Rajesh Ramanathan, Marc Posner & Robert A Fisher. (2013) Pediatric kidney transplantation: a review. Transplant Research and Risk Management 5, pages 21-31.
Read now
Read now
Mary M. Taj, Nedim Hadzic, Susan E. Height, Andrew Wotherspoon, Margaret Burke, Rachel Hobson, Maria Viskaduraki & C. Ross Pinkerton. (2012) Long-term outcome for immune suppression and immune related lymphoproliferative disorder: prospective data from the United Kingdom Children's Leukaemia and Cancer Group registry 1994–2004. Leukemia & Lymphoma 53:5, pages 842-848.
Read now
Read now
Bill G. Richendollar, Raymond E. Tsao, Paul Elson, Tao Jin, Roxanne Steinle, Brad Pohlman & Eric D. Hsi. (2009) Predictors of outcome in post-transplant lymphoproliferative disorder: an evaluation of tumor infiltrating lymphocytes in the context of clinical factors. Leukemia & Lymphoma 50:12, pages 2005-2012.
Read now
Read now
Amelie Kinch, Gunnar Öberg, Johan Arvidson, Kerstin I. Falk, Annika Linde & Karlis Pauksens. (2007) Post-transplant lymphoproliferative disease and other Epstein-Barr virus diseases in allogeneic haematopoietic stem cell transplantation after introduction of monitoring of viral load by polymerase chain reaction. Scandinavian Journal of Infectious Diseases 39:3, pages 235-244.
Read now
Read now
Boo Messahel, Mary M. Taj, Rachael Hobson, Nedim Hadzic, Alan Ramsay, Ian Hann & Ross Pinkerton. (2006) Single agent efficacy of rituximab in childhood immunosuppression related lymphoproliferative disease: a United Kingdom Children's Cancer Study Group (UKCCSG) retrospective review. Leukemia & Lymphoma 47:12, pages 2584-2589.
Read now
Read now
Articles from other publishers (62)
Laura McDonald, Roseann O’ Doherty, Eileen Ryan, Helen Enright, Eoghan Dunlea, Sarah Kelliher, Anne Fortune, Michael Fay, SW Maung, Ronan Desmond, Catherine Wall, Senthil Kumar, Derville O’ Shea, Kamal Fadalla, DG Connaghan & Liam Smyth. (2021) Posttransplant Lymphoproliferative Disorder After Solid Organ Transplant: A Heterogeneous, Aggressive Disorder. Clinical Lymphoma Myeloma and Leukemia 21:10, pages 694-700.
Crossref
Crossref
Christopher D. Blosser, Gregory Haber & Eric A. Engels. (2021) Changes in cancer incidence and outcomes among kidney transplant recipients in the United States over a thirty-year period. Kidney International 99:6, pages 1430-1438.
Crossref
Crossref
Donald E. Tsai & Mitchell E. Hughes. 2021. Post-Transplant Lymphoproliferative Disorders. Post-Transplant Lymphoproliferative Disorders
149
165
.
Raphael C. Bosse, Aaron J. Franke, William Paul SkeltonIVIV, Lindsey E. Woody, Rohit Bishnoi, Yu Wang, Sumita Bhaduri‐McIntosh, Dhanashree Rajderkar, Renata Shih, Nam H. Dang & William B. Slayton. (2020) Post Transplant Lymphoproliferative Disorder risk factors in children: Analysis of a 23‐year single‐institutional experience. Pediatric Transplantation 24:5.
Crossref
Crossref
Fang Kuan Chiou, Sue V. Beath, Bruce Morland, Jane Hartley, Indra van Mourik, Mona Abdel-Hady, Deirdre A. Kelly, Khalid Sharif & Girish L. Gupte. (2019) Comparison of Clinical Features and Outcome of Pediatric Posttransplant Lymphoproliferative Disorder in Recipients of Small Bowel Allograft Versus Isolated Liver Transplantation. Transplantation 104:7, pages 1429-1436.
Crossref
Crossref
Devika Gupta, Satish Mendonca, Sushmita Chakraborty & Tathagata Chatterjee. (2019) Post Transplant Lymphoproliferative Disorder. Indian Journal of Hematology and Blood Transfusion 36:2, pages 229-237.
Crossref
Crossref
Eman Marie, María Navallas, Oscar M. Navarro, Angela Punnett, Amer Shammas, Aaryan Gupta, Rose Chami, Manohar M. Shroff & Reza Vali. (2020) Posttransplant Lymphoproliferative Disorder in Children: A 360-degree Perspective. RadioGraphics 40:1, pages 241-265.
Crossref
Crossref
Rama Al Hamed, Abdul Hamid Bazarbachi & Mohamad Mohty. (2019) Epstein-Barr virus-related post-transplant lymphoproliferative disease (EBV-PTLD) in the setting of allogeneic stem cell transplantation: a comprehensive review from pathogenesis to forthcoming treatment modalities. Bone Marrow Transplantation 55:1, pages 25-39.
Crossref
Crossref
Arnaud G. L’Huillier, Anne I. Dipchand, Vicky L. Ng, Diane Hebert, Yaron Avitzur, Melinda Solomon, Bo-Yee Ngan, Simon Yeung, Derek Stephens, Angela S. Punnett, Michelle Barton & Upton D. Allen. (2019) Posttransplant Lymphoproliferative Disorder in Pediatric Patients: Characteristics of Disease in EBV-seropositive Recipients. Transplantation 103:11, pages e369-e374.
Crossref
Crossref
Nicholas Piening, Saxena Saurabh, Armando Salim Munoz Abraham, Hector Osei, Colleen Fitzpatrick & Jose Greenspon. (2019) Sterile necrotizing and non-necrotizing granulomas in a heart transplant patient with history of PTLD: A unique finding. International Journal of Surgery Case Reports 60, pages 8-12.
Crossref
Crossref
Seema Naik, Hong Zheng, Kevin Rakszawski, Clare Sample, Jeff Sample & Michael Bayerl. 2018. Organ Donation and Transplantation - Current Status and Future Challenges. Organ Donation and Transplantation - Current Status and Future Challenges.
Rohit Bishnoi, Ravneet Bajwa, Aaron J. Franke, William Paul SkeltonIVIV, Yu Wang, Niraj M. Patel, William Birdsall Slayton, Fei Zou & Nam H. Dang. (2017) Post-transplant lymphoproliferative disorder (PTLD): single institutional experience of 141 patients. Experimental Hematology & Oncology 6:1.
Crossref
Crossref
Renaud Snanoudj, Jacques Dantal, Céleste Lebbé & Christophe Legendre. 2017. Kidney Transplantation, Bioengineering and Regeneration. Kidney Transplantation, Bioengineering and Regeneration
525
542
.
Jade Le. (2016) Oncogenic γ Herpesviruses EBV and HHV8 in Kidney Transplantation. Seminars in Nephrology 36:5, pages 362-371.
Crossref
Crossref
Eugenia Giraldi, Massimo Provenzi, Valentino Conter, Michele Colledan, Stefania Bolognini, Carlo Foglia, Roberta Sebastiani, Roberto Fiocchi, Andrea Gianatti, Lorenzo D'Antiga & Alessandro Rambaldi. (2016) Risk-adapted Treatment for Severe B-Lineage Posttransplant Lymphoproliferative Disease After Solid Organ Transplantation in Children. Transplantation 100:2, pages 437-445.
Crossref
Crossref
Vikas R. Dharnidharka, Angela C. Webster, Olivia M. Martinez, Jutta K. Preiksaitis, Veronique Leblond & Sylvain Choquet. (2016) Post-transplant lymphoproliferative disorders. Nature Reviews Disease Primers 2:1.
Crossref
Crossref
Francesca Montanari, Dejan Radeski, Venkatraman Seshan, Bachir Alobeid, Govind Bhagat & Owen A. O'Connor. (2015) Recursive partitioning analysis of prognostic factors in post-transplant lymphoproliferative disorders (PTLD): a 120 case single institution series. British Journal of Haematology 171:4, pages 491-500.
Crossref
Crossref
Augusto Lauro, Mario Arpinati & Antonio D. Pinna. (2015) Managing the challenge of PTLD in liver and bowel transplant recipients. British Journal of Haematology 169:2, pages 157-172.
Crossref
Crossref
Xiaofan Li, Nainong Li, Ting Yang, Zhizhe Chen & Jianda Hu. (2015) Lymph Node Flow Cytometry as a Prompt Recognition of Ultra Early Onset PTLD: A Successful Case of Rituximab Treatment. Case Reports in Hematology 2015, pages 1-5.
Crossref
Crossref
Arun K. Singavi, Alexandra M. Harrington & Timothy S. Fenske. 2015. Non-Hodgkin Lymphoma. Non-Hodgkin Lymphoma
305
327
.
Sharad Sathyan, Madhu Bhaskaran & Vinay Nair. 2015. Onconephrology. Onconephrology
319
350
.
Ritesh Kumar, Divya Khosla, Rakesh Kapoor & Shreekant Bharti. (2013) Small Intestinal Lymphoma in a Post-Renal Transplant Patient: A Rare Case with Late Presentation. Journal of Gastrointestinal Cancer 45:S1, pages 2-5.
Crossref
Crossref
Jae-Ho Yoon, Seok Lee, Hee-Je Kim, Jong-Wook Lee, Woo-Sung Min, Byung Ha Chung, Chul Woo Yang, Yong-Soo Kim, Ji-Il Kim, In Sung Moon, Eun Ji Oh, Gyeong-Sin Park & Seok-Goo Cho. (2014) Comparative analysis of post-transplant lymphoproliferative disorder after kidney transplantation versus hematopoietic stem cell transplantation. Transplant International 27:7, pages 721-732.
Crossref
Crossref
Damian L. Turner, Claire L. Gordon & Donna L. Farber. (2014)
Tissue-resident T cells,
in situ
immunity and transplantation
. Immunological Reviews 258:1, pages 150-166.
Crossref
Crossref
Jan Styczynski, Lidia Gil, Gloria Tridello, Per Ljungman, J. Peter Donnelly, Walter van der Velden, Hamdy Omar, Rodrigo Martino, Constantijn Halkes, Maura Faraci, Koen Theunissen, Krzysztof Kalwak, Petr Hubacek, Simona Sica, Chiara Nozzoli, Franca Fagioli, Susanne Matthes, Miguel A. Diaz, Maddalena Migliavacca, Adriana Balduzzi, Agnieszka Tomaszewska, Rafael de la Camara, Anja van Biezen, Jennifer Hoek, Simona Iacobelli, Hermann Einsele & Simone Cesaro. (2013) Response to Rituximab-Based Therapy and Risk Factor Analysis in Epstein Barr Virus–Related Lymphoproliferative Disorder After Hematopoietic Stem Cell Transplant in Children and Adults: A Study From the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Clinical Infectious Diseases 57:6, pages 794-802.
Crossref
Crossref
Zeina Al-Mansour, Beverly P. Nelson & Andrew M. Evens. (2013) Post-Transplant Lymphoproliferative Disease (PTLD): Risk Factors, Diagnosis, and Current Treatment Strategies. Current Hematologic Malignancy Reports 8:3, pages 173-183.
Crossref
Crossref
A.M. Evens, S. Choquet, A.R. Kroll-Desrosiers, D. Jagadeesh, S.M. Smith, F. Morschhauser, V. Leblond, R. Roy, B. Barton, L.I. Gordon, M.K. Gandhi, D. Dierickx, D. Schiff, T.M. Habermann & R. Trappe. (2013) Primary CNS Posttransplant Lymphoproliferative Disease (PTLD): An International Report of 84 Cases in the Modern Era. American Journal of Transplantation 13:6, pages 1512-1522.
Crossref
Crossref
Xi Yang, Toshio Miyawaki & Hirokazu Kanegane. (2013) Lymphoproliferative disorders in immunocompromised individuals and therapeutic antibodies for treatment. Immunotherapy 5:4, pages 415-425.
Crossref
Crossref
Sophie CaillardRaphael PorcherFrançois ProvotJacques DantalSylvain ChoquetAntoine DurrbachEmmanuel MorelonValérie MoalBenedicte JanbonEric AlamartineClaire Pouteil NobleDelphine MorelNassim KamarMatthias BuchlerMarie France MamzerMarie Noelle PeraldiChristian HiesseEdith RenoultOlivier ToupanceJean Philippe RerolleSylvie DelmasPhilippe LangYvon LebranchuAnne Elisabeth HengJean Michel RebibouChristiane MoussonDenis GlotzJoseph RivalanAntoine ThierryIsabelle EtienneMarie Christine MoalLaetitia AlbanoJean François SubraNacera OualiPierre François WesteelMichel DelahousseRobert GeninBruno Hurault de LignyBruno Moulin. (2013) Post-Transplantation Lymphoproliferative Disorder After Kidney Transplantation: Report of a Nationwide French Registry and the Development of a New Prognostic Score. Journal of Clinical Oncology 31:10, pages 1302-1309.
Crossref
Crossref
A. M. Evens, S. Choquet, A. R. Kroll-Desrosiers, D. Jagadeesh, S. M. Smith, F. Morschhauser, V. Leblond, R. Roy, B. Barton, L. I. Gordon, M. K. Gandhi, D. Dierickx, D. Schiff, T. M. Habermann & R. Trappe. (2013) Primary CNS Posttransplant Lymphoproliferative Disease (PTLD): An International Report of 84 Cases in the Modern Era. American Journal of Transplantation, pages n/a-n/a.
Crossref
Crossref
T.G. Gross, M.A. Orjuela, S.L. Perkins, J.R. Park, J.C. Lynch, M.S. Cairo, L.M. Smith & R.J. Hayashi. (2012) Low-Dose Chemotherapy and Rituximab for Posttransplant Lymphoproliferative Disease (PTLD): A Children’s Oncology Group Report. American Journal of Transplantation 12:11, pages 3069-3075.
Crossref
Crossref
Mario Senechal, Sabrina Demers, Bernard Cantin, Christine Bourgault, Marie-Helene Leblanc, Joëlle Morin & Christian Couture. (2012) Usefulness and Limitations of Rituximab in Managing Patients With Lymphoproliferative Disorder After Heart Transplantation. Experimental and Clinical Transplantation 10:5, pages 513-518.
Crossref
Crossref
Min‐Chul Cho, Chan‐Jeoung Park, Jooryung Huh, Hyun‐Sook Chi, Seongsoo Jang, Cheolwon Suh, Kyoo‐Hyung Lee, Je‐Hwan Lee, Jong Jin Seo & Ho Joon Im. (2012)
Bone marrow findings of 23
K
orean post‐transplant lymphoproliferative disorder patients: a single‐center experience
. Clinical Transplantation 26:4.
Crossref
Crossref
Emina Emilia Torlakovic & Denis Bailey. (2012) Post-transplant lymphoproliferative disorders. Diagnostic Histopathology 18:7, pages 281-289.
Crossref
Crossref
Deepa Jagadeesh, Bruce A. Woda, Jacqueline Draper & Andrew M. Evens. (2012) Post Transplant Lymphoproliferative Disorders: Risk, Classification, and Therapeutic Recommendations. Current Treatment Options in Oncology 13:1, pages 122-136.
Crossref
Crossref
Samar Issa, M. Beatriz S. Lopes & David Schiff. 2012. Lymphoma and Leukemia of the Nervous System. Lymphoma and Leukemia of the Nervous System
181
198
.
V.R. Dharnidharka, K.L. Martz, D.M. Stablein & M.R. Benfield. (2011) Improved Survival with Recent Post-Transplant Lymphoproliferative Disorder (PTLD) in Children with Kidney Transplants. American Journal of Transplantation 11:4, pages 751-758.
Crossref
Crossref
Andrew M. Evens, Rupali Roy, Danielle Sterrenberg, Michelle Z. Moll, Amy Chadburn & Leo I. Gordon. (2010) Post-Transplantation Lymphoproliferative Disorders: Diagnosis, Prognosis, and Current Approaches to Therapy. Current Oncology Reports 12:6, pages 383-394.
Crossref
Crossref
Thomas G. Gross, Barbara Savoldo & Angela Punnett. (2010) Posttransplant Lymphoproliferative Diseases. Pediatric Clinics of North America 57:2, pages 481-503.
Crossref
Crossref
Andrew M. EvensKevin A. DavidIrene HelenowskiBeverly NelsonDixon KaufmanSheetal M. KircherAlla GimelfarbElise HattersleyLauren A. MauroBorko JovanovicAmy ChadburnPatrick StiffJane N. WinterJayesh MehtaKoen Van BesienStephanie GregoryLeo I. GordonJamile M. ShammoScott E. SmithSonali M. Smith. (2010) Multicenter Analysis of 80 Solid Organ Transplantation Recipients With Post-Transplantation Lymphoproliferative Disease: Outcomes and Prognostic Factors in the Modern Era. Journal of Clinical Oncology 28:6, pages 1038-1046.
Crossref
Crossref
Alicia K. Morgans, Ran Reshef & Donald E. Tsai. (2010) Posttransplant Lymphoproliferative Disorder Following Kidney Transplant. American Journal of Kidney Diseases 55:1, pages 168-180.
Crossref
Crossref
Tapan Maniar & Donald Tsai. 2010. Post-Transplant Lymphoproliferative Disorders. Post-Transplant Lymphoproliferative Disorders
105
116
.
Voravit Ratanatharathorn, Steven Pavletic & Joseph P. Uberti. (2009) Clinical applications of rituximab in allogeneic stem cell transplantation: Anti-tumor and immunomodulatory effects. Cancer Treatment Reviews 35:8, pages 653-661.
Crossref
Crossref
Jason S. KnightAlexander TsodikovDiane M. CibrikCharles W. RossMark S. KaminskiDouglas W. Blayney. (2009) Lymphoma After Solid Organ Transplantation: Risk, Response to Therapy, and Survival at a Transplantation Center. Journal of Clinical Oncology 27:20, pages 3354-3362.
Crossref
Crossref
Emilio V. Perez-Jorge, Steven D. Burdette & Paul Gibbs. (2009) A 52-Year-Old Man With Anorexia and Numerous Thoracic and Abdominal Lesions 20 Years After a Renal Transplant. Infectious Diseases in Clinical Practice 17:4, pages 261-263.
Crossref
Crossref
Elizabeth Schauer, Steven Webber, Laurence Kingsley, Michael Green & David Rowe. (2009) Increased Ig-null B lymphocytes in the peripheral blood of pediatric solid organ transplant recipients with elevated Epstein-Barr viral loads. Pediatric Transplantation 13:3, pages 311-318.
Crossref
Crossref
Vikas R. Dharnidharka & Carlos E. Araya. (2009) Post-transplant lymphoproliferative disease. Pediatric Nephrology 24:4, pages 731-736.
Crossref
Crossref
J.E. Spahr, R.B. Love, M. Francois, K. Radford & K.C. Meyer. (2007) Lung transplantation for cystic fibrosis: Current concepts and one center's experience. Journal of Cystic Fibrosis 6:5, pages 334-350.
Crossref
Crossref
R. Sharma, L. Koller, P. Barclay & C. Liddle. (2007) Evaluation of the off-label usage of rituximab in a large teaching hospital in New South Wales. Internal Medicine Journal 37:8, pages 569-571.
Crossref
Crossref
Sylvain Choquet, Stephan Oertel, Veronique LeBlond, Hanno Riess, Nathalie Varoqueaux, Bernd Dörken & Ralf Trappe. (2007) Rituximab in the management of post-transplantation lymphoproliferative disorder after solid organ transplantation: proceed with caution. Annals of Hematology 86:8, pages 599-607.
Crossref
Crossref
Thomas M. Habermann. (2007) Antibody Therapy in Aggressive Lymphomas. Hematology 2007:1, pages 257-264.
Crossref
Crossref
T. G. Gross & B. Shiramizu. 2007. Pediatric Lymphomas. Pediatric Lymphomas
233
258
.
S. Caillard, C. Lelong, F. Pessione & B. Moulin. (2006) Post-Transplant Lymphoproliferative Disorders Occurring After Renal Transplantation in Adults: Report of 230 Cases From the French Registry. American Journal of Transplantation 6:11, pages 2735-2742.
Crossref
Crossref
Martin R Zamora. (2006) Impact of viral infections on lung transplant outcomes. Current Opinion in Organ Transplantation 11:5, pages 475-482.
Crossref
Crossref
WAI H LIM, GRAEME R RUSS & PATRICK TH COATES. (2006) Review of Epstein–Barr virus and post-transplant lymphoproliferative disorder post-solid organ transplantation (Review Article). Nephrology 11:4, pages 355-366.
Crossref
Crossref
Joseph F. Buell, Thomas G. Gross, Mark J. Thomas, Guy Neff, Chandar Muthiah, Rita Alloway, Frederick C. Ryckman, Gregory M. Tiao & E. Steve Woodle. (2006) Malignancy in pediatric transplant recipients. Seminars in Pediatric Surgery 15:3, pages 179-187.
Crossref
Crossref
Didier Decaudin, Fanny Baran Marszak, Jérôme Couturier, Claire Mathiot, Antoine Martin, Fariba Némati, Olivier Lantz, James di Santo, Philippe Arnaud, Vincent Bordier, Anne Vincent-Salomon & Marie-France Poupon. (2006) High efficacy of combined rituximab and gemcitabine on Epstein–Barr virus-associated human B-cell lymphoma obtained after Hodgkin's xenograft in immunodeficient mice. Anti-Cancer Drugs 17:6, pages 685-695.
Crossref
Crossref
Jakub Svoboda, Robert Kotloff & Donald E. Tsai. (2006) Management of patients with post-transplant lymphoproliferative disorder: the role of rituximab. Transplant International 19:4, pages 259-269.
Crossref
Crossref
Katherine H. Flanagan & Daniel C. Brennan. (2006) EBV-associated recurrent Hodgkin's disease after renal transplantation. Transplant International 19:4, pages 338-341.
Crossref
Crossref
Federico Aucejo, George Rofaiel & Charles Miller. (2006) Who is at risk for post-transplant lymphoproliferative disorders (PTLD) after liver transplantation?. Journal of Hepatology 44:1, pages 19-23.
Crossref
Crossref
Ashokkumar B. Jain, Amadeo Marcos, Renu Pokharna, Ron Shapiro, Paulo A. Fontes, Wallace Marsh, Ravi Mohanka & John J. Fung. (2005) Rituximab (Chimeric Anti-CD20 Antibody) for Posttransplant Lymphoproliferative Disorder after Solid Organ Transplantation in Adults: Long-Term Experience from a Single Center. Transplantation 80:12, pages 1692-1698.
Crossref
Crossref
. (2005) Current Awareness in Hematological Oncology. Hematological Oncology 23:1, pages 41-48.
Crossref
Crossref